Your browser doesn't support javascript.
loading
Adverse Events Following Immunization With Combined vs Concurrent Monovalent Hepatitis A and Typhoid Vaccines in Children.
Furuya-Kanamori, Luis; Dutton, Paul; Leeb, Alan; Mills, Deborah J; Andrews, Ross; Lau, Colleen L.
Affiliation
  • Furuya-Kanamori L; Research School of Population Health, College of Health and Medicine, Australian National University, Canberra, Australia.
  • Dutton P; Research School of Population Health, College of Health and Medicine, Australian National University, Canberra, Australia.
  • Leeb A; Illawarra Medical Centre, Perth, Australia.
  • Mills DJ; Research School of Population Health, College of Health and Medicine, Australian National University, Canberra, Australia.
  • Andrews R; Travel Medicine Alliance Clinics, Brisbane, Australia.
  • Lau CL; Research School of Population Health, College of Health and Medicine, Australian National University, Canberra, Australia.
J Pediatric Infect Dis Soc ; 10(2): 192-195, 2021 Mar 26.
Article in En | MEDLINE | ID: mdl-32333678
Combined hepatitis A and typhoid vaccine is available in Australia, but licensed for use from age 16 years; however it is used "off-label" in children. The combined vaccine is well tolerated in children aged 2-16 years and the risk of adverse events is similar to those receiving concurrent monovalent vaccines.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Typhoid-Paratyphoid Vaccines / Hepatitis A Limits: Adolescent / Child / Humans Language: En Journal: J Pediatric Infect Dis Soc Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Typhoid-Paratyphoid Vaccines / Hepatitis A Limits: Adolescent / Child / Humans Language: En Journal: J Pediatric Infect Dis Soc Year: 2021 Document type: Article Affiliation country: Country of publication: